Gene expression of OR4N5, OR2A7, OR6C68, and OR10K2 in 6 cancers vs normal control
| Gene name . | Breast carcinoma . | Colorectal carcinoma . | Glioblastoma . | |||
|---|---|---|---|---|---|---|
| P value . | log2FC . | P value . | log2FC . | P value . | log2FC . | |
| OR4N5 | 5.08E−05 | −3.3 | .000203805 | −3 | .037922805 | −1.5 |
| OR10K2 | 1.99E−16 | −5 | 1.61E−21 | −5.8 | 4.81E−06 | −2.6 |
| OR2A7 | 2.47E−19 | −4.7 | 8.42E−23 | −5.5 | 1.18E−05 | −2.2 |
| OR6C68 | 1.25E−06 | −3.4 | 9.69E−09 | −3.8 | .00392438 | −1.8 |
| Gene name . | Breast carcinoma . | Colorectal carcinoma . | Glioblastoma . | |||
|---|---|---|---|---|---|---|
| P value . | log2FC . | P value . | log2FC . | P value . | log2FC . | |
| OR4N5 | 5.08E−05 | −3.3 | .000203805 | −3 | .037922805 | −1.5 |
| OR10K2 | 1.99E−16 | −5 | 1.61E−21 | −5.8 | 4.81E−06 | −2.6 |
| OR2A7 | 2.47E−19 | −4.7 | 8.42E−23 | −5.5 | 1.18E−05 | −2.2 |
| OR6C68 | 1.25E−06 | −3.4 | 9.69E−09 | −3.8 | .00392438 | −1.8 |
| Gene name . | Hepatobiliary carcinoma . | NSC lung carcinoma . | Pancreatic adenocarcinoma . | |||
|---|---|---|---|---|---|---|
| P value . | log2FC . | P value . | log2FC . | P value . | log2FC . | |
| OR4N5 | .04766668 | −1.9 | 5.79E−05 | −2.5 | 4.44E−05 | −3.4 |
| OR10K2 | .00153234 | −2.3 | 7.77E−11 | −3.7 | 1.18E−07 | −3.5 |
| OR2A7 | .0001452 | −2.7 | 6.51E−16 | −4.1 | 2.37E−07 | −3 |
| OR6C68 | .00590347 | −2.3 | 5.17E−06 | −2.6 | 1.46E−10 | −4.4 |
| Gene name . | Hepatobiliary carcinoma . | NSC lung carcinoma . | Pancreatic adenocarcinoma . | |||
|---|---|---|---|---|---|---|
| P value . | log2FC . | P value . | log2FC . | P value . | log2FC . | |
| OR4N5 | .04766668 | −1.9 | 5.79E−05 | −2.5 | 4.44E−05 | −3.4 |
| OR10K2 | .00153234 | −2.3 | 7.77E−11 | −3.7 | 1.18E−07 | −3.5 |
| OR2A7 | .0001452 | −2.7 | 6.51E−16 | −4.1 | 2.37E−07 | −3 |
| OR6C68 | .00590347 | −2.3 | 5.17E−06 | −2.6 | 1.46E−10 | −4.4 |
Gene expression levels of OR4N5, OR2A7, OR6C68, and OR10K2 in 6 types of cancer compared to normal controls, based on data from the E-GEOD-68086 data set (EMBL-EBI). OR4N5, OR2A7, and OR6C68 are predominantly expressed in blood tissues, whereas OR10K2, induced by CSH71, is included as a control. All data are presented as log2FC with P values <.05.
EMBL-EBI, European Molecular Biology Laboratory – European Bioinformatics Institute; FC, fold change; NSC, non-small cell.